B细胞非霍奇金淋巴瘤中肿瘤内调节性T细胞的多样性
本研究应用单细胞RNA测序和T细胞受体测序结合高维流式细胞术,比较弥漫大B细胞淋巴瘤、滤泡性淋巴瘤与非恶性扁桃体组织中肿瘤浸润调节性T细胞的异质性。鉴定出静息、活化及非常规LAG3+FOXP3-三种转录状态,活化调节性T细胞在B-NHL肿瘤中富集、共表达多种检查点受体且免疫抑制活性更强。在两个独立滤泡性淋巴瘤队列中,活化调节性T细胞为主要亚群,高丰度与不良预后相关。
要点
- B-NHL肿瘤浸润Treg存在静息、活化和非常规LAG3+FOXP3-三种转录状态。
- 活化Treg在B-NHL肿瘤中富集,共表达检查点受体,免疫抑制活性强于静息Treg。
- 滤泡性淋巴瘤中活化Treg高丰度与不良预后相关。
核心结论
- 浸润B-NHL肿瘤的Treg在转录和功能上具有多样性。
- 高免疫抑制性的活化Treg富集于肿瘤组织,在外周血中缺失。
- 更深入理解B-NHL中Treg异质性可能为合理药物设计开辟新路径,促进选择性靶向以改善抗肿瘤免疫。
研究设计与样本
- 应用单细胞RNA测序和T细胞受体测序结合高维流式细胞术,比较弥漫大B细胞淋巴瘤、滤泡性淋巴瘤与非恶性扁桃体组织中肿瘤内Treg的异质性。
- 利用计算方法开发独特基因特征矩阵,在具有批量基因表达数据的队列中枚举各Treg亚群。
主要发现
- 鉴定出3种不同的Treg转录状态:静息、活化和非常规LAG3+FOXP3- Treg。
- 活化Treg在B-NHL肿瘤中富集,共表达几种检查点受体,免疫抑制活性强于静息Treg。
- 在滤泡性淋巴瘤中,活化Treg比其他细胞类型更靠近CD4+和CD8+ T细胞。
- 在两个独立滤泡性淋巴瘤队列中,活化Treg是主要亚群,高丰度与不良预后相关。
关键数值与推荐
- 鉴定出3种Treg转录状态:静息、活化和非常规LAG3+FOXP3- Treg。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Tumor-infiltrating regulatory T cells (Tregs) contribute to an immunosuppressive tumor microenvironment. Despite extensive studies, the prognostic impact of tumor-infiltrating Tregs in B-cell non-Hodgkin lymphomas (B-NHLs) remains unclear. Emerging studies suggest substantial heterogeneity in the phenotypes and suppressive capacities of Tregs, emphasizing the importance of understanding Treg diversity and the need for additional markers to identify highly suppressive Tregs. Here, we applied single-cell RNA sequencing and T-cell receptor sequencing combined with high-dimensional cytometry to decipher the heterogeneity of intratumoral Tregs in diffuse large B-cell lymphoma and follicular lymphoma (FL), compared with that in nonmalignant tonsillar tissue. We identified 3 distinct transcriptional states of Tregs: resting, activated, and unconventional LAG3+FOXP3- Tregs. Activated Tregs were enriched in B-NHL tumors, coexpressed several checkpoint receptors, and had stronger immunosuppressive activity compared with resting Tregs. In FL, activated Tregs were found in closer proximity to CD4+ and CD8+ T cells than other cell types. Furthermore, we used a computational approach to develop unique gene signature matrices, which were used to enumerate each Treg subset in cohorts with bulk gene expression data. In 2 independent FL cohorts, activated Tregs was the major subset, and high abundance was associated with adverse outcome. This study demonstrates that Tregs infiltrating B-NHL tumors are transcriptionally and functionally diverse. Highly immunosuppressive activated Tregs were enriched in tumor tissue but absent in the peripheral blood. Our data suggest that a deeper understanding of Treg heterogeneity in B-NHL could open new paths for rational drug design, facilitating selective targeting to improve antitumor immunity.
引用
- Spasevska I, Sharma A, Steen CB, et al. Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma. Blood Adv. 2023. PMID: 37695745. doi:10.1182/bloodadvances.2023010158
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。